- Report
- February 2024
- 115 Pages
Global
From €4403EUR$4,750USD£3,698GBP
- Report
- February 2024
- 120 Pages
Global
From €4403EUR$4,750USD£3,698GBP
- Drug Pipelines
- April 2024
- 210 Pages
Global
From €2317EUR$2,500USD£1,946GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1159EUR$1,250USD£973GBP
- Report
- February 2024
- 115 Pages
Global
From €4403EUR$4,750USD£3,698GBP
- Report
- February 2024
- 120 Pages
Global
From €4403EUR$4,750USD£3,698GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3476EUR$3,750USD£2,920GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1390EUR$1,500USD£1,168GBP
- Report
- November 2023
- 188 Pages
Global
From €6952EUR$7,500USD£5,839GBP
- Report
- January 2024
- 200 Pages
Global
From €3847EUR$4,150USD£3,231GBP
- Report
- March 2024
- 175 Pages
Global
From €4635EUR$5,000USD£3,893GBP
- Report
- February 2024
- 175 Pages
Global
From €4635EUR$5,000USD£3,893GBP
- Report
- October 2023
- 172 Pages
Global
From €4542EUR$4,900USD£3,815GBP
- Report
- December 2023
- 140 Pages
Global
From €4125EUR$4,450USD£3,465GBP
- Report
- December 2023
- 143 Pages
Global
From €4125EUR$4,450USD£3,465GBP
- Clinical Trials
- February 2024
- 1264 Pages
Global
From €2317EUR$2,500USD£1,946GBP
- Report
- May 2024
- 200 Pages
Global
From €3847EUR$4,150USD£3,231GBP
- Report
- March 2024
- 200 Pages
Global
From €3847EUR$4,150USD£3,231GBP
- Report
- March 2024
- 200 Pages
Global
From €3847EUR$4,150USD£3,231GBP
- Report
- January 2024
- 200 Pages
Global
From €3847EUR$4,150USD£3,231GBP
The Breast Cancer market is a subset of the Women's Health market, focusing on the diagnosis, treatment, and prevention of breast cancer. It includes a range of products and services, from medical devices and pharmaceuticals to patient education and support. Breast cancer is the most common cancer among women worldwide, and the market is driven by the need to improve early detection and treatment outcomes.
The Breast Cancer market is highly competitive, with a range of players from large multinationals to small start-ups. Companies in the market include Roche, Novartis, AstraZeneca, Pfizer, Merck, and Johnson & Johnson, as well as smaller players such as Myriad Genetics, Genomic Health, and Natera. Show Less Read more